BRG Drug Policy Review 2022–2023

The Inflation Reduction Act’s drug pricing reforms headlined a flurry of drug-related policy activity over the last year.  The action was not limited to Congress, as the Biden Administration took some Federal action to lower drug prices but held off on another, Federal courts decided cases centered on financial flows in the drug value chain, and states adopted interventions geared at lowering costs for patients. In this paper, BRG traverses the landscape of drug pricing reform efforts in 2022-23 and highlight what to watch in the coming year. Click to read more. 

Weekly Medicaid Update

The brief highlights recent Medicaid policy developments in key states over the past week, including, but not limited to: AZ: Adds additional screening criteria for behavioral health providers CT: Group home and day program workers on strike IN: Announced new non-medical transportation service to respite care facilities Click to read more. 

Managed Care Friday

12,000: The number of people who called into the National Maternal Mental Health Hotline in its first 11 months. The hotline, launched on Mother’s Day in 2022, can be called or texted with any type of concern related to maternal health, and about 70% of contacts so far have been phone calls. The US has higher maternal mortality rates compared to other developed countries, and the hotline was launched as part of a broader effort to reduce these rates. New E&M Requirement: Effective May 25, Cigna will require that providers submit office notes for E&M claims 99212-99215 when...

Weekly Medicaid Update

The brief highlights recent Medicaid policy developments in key states over the past week, including, but not limited to: AZ: Announces fraud allegations against 100+ behavioral health providers​ CA: Governor releases May Budget Revision​ NH: Proposed SPA would allow reimbursement for Self-Directed Personal Assistance Services Click to read more.